Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00731926
Other study ID # H-0707-028-212
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received May 20, 2008
Last updated August 10, 2008
Start date September 2007
Est. completion date February 2008

Study information

Verified date August 2008
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority Korea: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

oligomerized litchi fruit extract may enhance the submaximal endurance exercise performance


Description:

Regular physical exercise has many beneficial effects, but it has been reported that strenuous exercise could elevate the production of free radical and other reactive oxygen species (ROS) which eventually injure the tissues and decrease the muscle function.So many kinds of antioxidant supplementations have been tried to decrease the muscle fatigue and enhance the exercise performance. polyphenolic flavonoids abundant in fruits and leafy vegetables have strong antioxidant effect. oligomerized litchi fruit extract has strong antioxidant capacity and higher bioavailability compared to that of grape seed polyphenol. The aim of this study was to determine whether oligomerized litchi fruit extract could induce endurance exercise performance more than Vit C + Vit E mixture or placebo could do. Therefore, we designed double blind randomized controlled trial, setting the change of running time to exhaustion under submaximal treadmill test as the primary endpoint.


Recruitment information / eligibility

Status Completed
Enrollment 69
Est. completion date February 2008
Est. primary completion date January 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- healthy men over 20 years old non-smoker

Exclusion Criteria:

- BMI>25 or body fat>25% he who intakes the antioxidant supplement in recent 2 weeks

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Oligomerized litchi fruit extract
100mg at once twice a day for 1 month
VItamin C + Vitamin E mixture
Vitamin C 400mg + Vitamin E 160IU at once twice a day for 1 month
Other:
placebo
twice a day for 1 month

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Seoul National University Hospital University of California, Davis

Outcome

Type Measure Description Time frame Safety issue
Primary change of running time to exhaustion under 80% of maximal heart rate 1 month No
Secondary VO2max, anaerobic threshold 1 month No
See also
  Status Clinical Trial Phase
Completed NCT01233037 - Markers of Endothelial Function and Exercise CapaciTy in Patients With Left Ventricular Assist Devices (EFECT LVAD) N/A
Completed NCT06010459 - Reference Values for the Six-minute Pegboard and Ring Test in Healthy Adults in Turkey
Recruiting NCT01016431 - Effects of Atrial Rate-adaptive Pacing on Exercise Capacity in Patients With Chronic Heart Failure Complicated by Chronotropic Incompetence Phase 4
Completed NCT03849300 - Impacts of Aquatic vs Land Walking on Vascular Health and Exercise Tolerance in Patients With Peripheral Artery Disease N/A
Not yet recruiting NCT03866915 - Validity of Aortic Pulse Wave Velocity in Predicting the 6- Minute Walking Test Before Major Non-cardiac Surgery
Completed NCT04734743 - Muscle Strength, Functional Capacity, Respiratory Function and Quality Of Life In Cystic Fibrosis Patients N/A
Completed NCT04767477 - Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors N/A
Recruiting NCT02102321 - Does Treating Hookworm Improve Productivity of Small Subsistence Farmers N/A
Completed NCT02779972 - Age Related Changes in Cardiac Physiology as a Predictor of Exercise Tolerance N/A
Enrolling by invitation NCT05608603 - Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications
Completed NCT03190304 - The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure Phase 4
Completed NCT03936348 - Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients N/A
Completed NCT04089410 - Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status N/A
Recruiting NCT05379608 - Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection. N/A
Completed NCT01418248 - Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease N/A